Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
20.30
-0.41 (-1.98%)
Nov 20, 2026, 3:00 PM CST
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,684 employees as of June 30, 2026. The number of employees increased by 81 or 0.20% since the number was reported on December 31, 2025. That makes Shanghai Fosun Pharmaceutical (Group) the 883rd largest employer in the world and 75th in China.
Employees
40,684
Change
81
Growth
0.20%
Revenue / Employee
1.05M CNY
Profits / Employee
86.56K CNY
Market Cap
49.60B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 40,684 | 81 | 0.20% |
| Dec 31, 2025 | 40,603 | 46 | 0.11% |
| Dec 31, 2024 | 40,557 | 187 | 0.46% |
| Dec 31, 2023 | 40,370 | 1,971 | 5.13% |
| Dec 31, 2022 | 38,399 | 2,120 | 5.84% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| China Resources Sanjiu Medical & Pharmaceutical | 30,304 |
| Huadong Medicine | 19,095 |
| Beijing Tongrentang | 17,284 |
| Humanwell Healthcare (Group) | 17,153 |
| Zhejiang NHU Company | 11,508 |
| Shijiazhuang Yiling Pharmaceutical | 11,343 |
| Changchun High-Tech Industry (Group) | 10,080 |
| Dong-E-E-Jiao | 4,345 |
Shanghai Fosun Pharmaceutical (Group) News
- 24 days ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: Q3 2026 - Filings
- 4 weeks ago - At ESMO 2026, Sun Pharma to Present Long-Term Follow-up Data on UNLOXCYT® (cosibelimab-ipdl) from One of the Largest Prospective Studies in Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) - PRNewsWire
- 4 weeks ago - Sun Pharma Announces UNLOXCYT® (cosibelimab-ipdl) Has Received a Category 2A Preferred Designation in the Updated NCCN Guidelines for Locally Advanced Cutaneous Squamous Cell Carcinoma (laCSCC) Patients Who Are Not Candidates for Curative Surgery or Curat - PRNewsWire
- 7 weeks ago - India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say - Reuters
- 2 months ago - Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion - PRNewsWire
- 2 months ago - Fosun Pharma Announces 2026 Interim Results - PRNewsWire
- 2 months ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: Q2 2026 - Filings
- 6 months ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: Q1 2026 - Filings